APC on compounding-safety roundtable

APC CEO Scott Brunner will be one of the panelists at “Considering the Safety of the Medicine Supply amid Growing Popularity of Unapproved Versions* of GLP-1,” a live (in-person or virtual) panel discussion hosted by the American Enterprise Institute this coming Wednesday, April 9 from noon to 1:30 p.m. EDT in Washington, DC.

The questions at hand: How can patients know whether online companies dispensing GLP-1 drugs are using legitimate sources for their medications? What’s the regulatory landscape like, and what are the patient-safety considerations? And what’s the role of compounding pharmacies?

Join Scott and other experts as they discuss the changing GLP-1 landscape. It’s free, but registration is required whether you’ll be there in person or virtually; click the link above.

* Seriously? “Unapproved Versions” sounds like it comes from a drugmaker press release. Hospitals use compounded drugs all the time and no one is calling those “unapproved.”